Both in Biotechnology
Silexion Therapeutics vs VivoSim Labs
Over the past year SLXN returned −99.6% and VIVS returned −93.6%; their daily moves had a correlation of 0.07.
SLXN −99.6% VIVS −93.6%Growth of $1, one year, split-adjusted
| Metric | SLXN | VIVS |
|---|---|---|
| Price | $0.1532 | $0.1457 |
| Market cap | $2.2M | $2.0M |
| Today | −7.54% | −3.06% |
| 1 month | −51.9% | −28.0% |
| 6 months | −97.6% | −89.9% |
| Year to date | −99.2% | −92.0% |
| 1 year | −99.6% | −93.6% |
| Revenue growth (YoY) | — | −51.4% |
| Gross margin | — | 100.0% |
| Net margin | — | −7433.3% |
| P/E (TTM) | — | — |
| Price / sales | — | 17.4× |
| Net cash | — | $1.7M |
| Dividend yield | — | — |
| Volatility (60d) | 240.6% | 116.0% |
| Short % of float | 3.5% | 4.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).